secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRC HEALTH (NRC)
CIK:        0000070487
Form:       8-K
Filed at:   2023-08-03T23:59:59+00:00
Accession:  0001437749-23-021779
Event type: earnings
Sentiment:  negative
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

National Research reports Q2 2023 diluted EPS $0.29, down from $0.33 YoY; new sales up 53%
--------------------------------------------------------------------------------

- Diluted EPS $0.29 for Q2 2023 vs $0.33 for Q2 2022, a 12% decrease.
- New sales increased 53% compared to Q2 2022.
- Human Understanding Program adopted by 39 healthcare organizations through June 30.
- Capital allocation: $4.2M innovation/growth, $3.0M dividends, $1.8M share repurchases in Q2.
- Operating margins improved in Q2 2023 compared to Q1 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/70487/000143774923021779/0001437749-23-021779-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/70487/000143774923021779/nrc20230802_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-021779

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer